World's Best Scientists 2026 revealed!
Jerold S. Harmatz

Jerold S. Harmatz

D-Index & Metrics

Medicine

D-Index
93
Citations
22783
World Ranking
11039
National Ranking
5683

Overview

Jerold S. Harmatz is affiliated with Tufts University in the United States and has contributed to research primarily in the fields of Medicine and Pharmacology, Toxicology, and Pharmaceutics. Their work intersects with several subfields, including Pharmacology, Physiology, Psychiatry and Mental Health, Geriatrics and Gerontology, as well as Pediatrics, Perinatology, and Child Health.

The scientist's research covers a range of topics, notably Pharmacogenetics and Drug Metabolism, Pharmacology and Obesity Treatment, Epilepsy Research and Treatment, Pharmaceutical Practices and Patient Outcomes, Pharmaceutical Studies and Practices, Drug Transport and Resistance Mechanisms, and Neurotransmitter Receptor Influence on Behavior.

Jerold S. Harmatz has published in multiple scholarly journals. The frequent venues for their publications include:

  • The Journal of Clinical Pharmacology
  • British Journal of Clinical Pharmacology
  • Journal of Clinical Psychopharmacology
  • Journal of Pharmacy and Pharmacology

Among recent papers authored or coauthored by Harmatz, the following are notable:

  • Effect of lipophilicity on drug distribution and elimination: Influence of obesity (2021, British Journal of Clinical Pharmacology)
  • Slow Accumulation and Elimination of Diazepam and Its Active Metabolite With Extended Treatment in the Elderly (2020, The Journal of Clinical Pharmacology)
  • Drug Disposition in Subjects With Obesity: The Research Work of Darrell R. Abernethy (2022, The Journal of Clinical Pharmacology)
  • Diazepam in the Elderly: Looking Back, Ahead, and at the Evidence (2020, Journal of Clinical Psychopharmacology)
  • Mechanism of dasabuvir inhibition of acetaminophen glucuronidation (2021, Journal of Pharmacy and Pharmacology)

Harmatz frequently collaborates with several researchers, including:

  • David J. Greenblatt
  • Christopher D. Bruno
  • Christina R. Chow
  • Qingchen Zhang
  • Su Duan

Best Publications

  • Effect of Age, Gender, and Obesity on Midazolam Kinetics

    David J. Greenblatt;Darrell R. Abernethy;Ann Locniskar;Jerold S. Harmatz

  • Dose-Dependent Pharmacokinetics and Psychomotor Effects of Caffeine in Humans

    Gary B. Kaplan;David J. Greenblatt;Bruce L. Ehrenberg;Jill E. Goddard

  • Diazepam disposition determinants.

    David J Greenblatt;David J Greenblatt;David J Greenblatt;Marcia Divoll Allen;Marcia Divoll Allen;Marcia Divoll Allen;Jerold S Harmatz;Jerold S Harmatz;Jerold S Harmatz;Richard I Shader;Richard I Shader;Richard I Shader

  • A new scale for clinical assessment in geriatric populations: Sandoz Clinical Assessment--Geriatric (SCAG).

    Richard I. Shader;Jerold S. Harmatz;Carl Salzman

  • A double-blind placebo controlled study of desipramine in the treatment of ADD. I, Efficacy

    J. Biederman;R. J. Baldessarini;V. Wright;D. Knee

  • Sensitivity to Triazolam in the Elderly

    D. J. Greenblatt;J. S. Harmatz;L. Shapiro;N. Engelhardt

  • Triazolam biotransformation by human liver microsomes in vitro: effects of metabolic inhibitors and clinical confirmation of a predicted interaction with ketoconazole.

    L. L. Von Moltke;D. J. Greenblatt;J. S. Harmatz;Su Xiang Duan

  • Midazolam Hydroxylation by Human Liver Microsomes In Vitro: Inhibition by Fluoxetine, Norfluoxetine, and by Azole Antifungal Agents

    Lisa L. von Moltke;David J. Greenblatt;Jürgen Schmider;Su Xiang Duan

  • Protease inhibitors as inhibitors of human cytochromes P450: high risk associated with ritonavir

    Lisa L. von Moltke;David J. Greenblatt;Jeffrey M. Grassi;Brian W. Granda

  • Oxazepam kinetics: effects of age and sex.

    D J Greenblatt;M Divoll;J S Harmatz;R I Shader

  • In Vitro Approaches to Predicting Drug Interactions In Vivo

    Lisa L von Moltke;Lisa L von Moltke;David J Greenblatt;David J Greenblatt;Jürgen Schmider;Jürgen Schmider;C.Eugene Wright

  • Pharmacokinetics and Bioavailability of Intravenous, Intramuscular, and Oral Lorazepam in Humans

    D. J. Greenblatt;R. I. Shader;K. Franke;D. S. MacLAUGHLIN

  • Comparison between cytochrome P450 (CYP) content and relative activity approaches to scaling from cDNA-expressed CYPs to human liver microsomes: ratios of accessory proteins as sources of discrepancies between the approaches.

    Karthik Venkatakrishnan;Lisa L. von Moltke;Michael H. Court;Jerold S. Harmatz

  • Escitalopram (S-citalopram) and its metabolites in vitro: cytochromes mediating biotransformation, inhibitory effects, and comparison to R-citalopram.

    Lisa L. von Moltke;David J. Greenblatt;Gina M. Giancarlo;Brian W. Granda

  • Clinical pharmacokinetics of anxiolytics and hypnotics in the elderly. Therapeutic considerations (Part II).

    David J. Greenblatt;Jerold S. Harmatz;Richard I. Shader

  • Time course of recovery of cytochrome p450 3A function after single doses of grapefruit juice.

    David J. Greenblatt;Lisa L. von Moltke;Jerold S. Harmatz;Gengsheng Chen

  • Clinical Pharmacokinetics of Anxiolytics and Hypnotics in the Elderly

    David J. Greenblatt;David J. Greenblatt;Jerold S. Harmatz;Jerold S. Harmatz;Richard I. Shader;Richard I. Shader

  • O- and N-demethylation of venlafaxine in vitro by human liver microsomes and by microsomes from cDNA-transfected cells: effect of metabolic inhibitors and SSRI antidepressants

    Steven M Fogelman;Jürgen Schmider;Karthik Venkatakrishnan;Lisa L von Moltke

  • Benzodiazepines: a summary of pharmacokinetic properties.

    DJ Greenblatt;RI Shader;M Divoll;JS Harmatz

  • Inhibitors of Alprazolam Metabolism in Vitro: Effect of Serotonin-Reuptake-Inhibitor Antidepressants, Ketoconazole and Quinidine

    L L von Moltke;D J Greenblatt;M M Cotreau-Bibbo;J S Harmatz

Frequent Co-Authors

David J. Greenblatt
David J. Greenblatt Tufts University
Richard I. Shader
Richard I. Shader Tufts University
Lisa L. von Moltke
Lisa L. von Moltke Tufts University
David B. Herzog
David B. Herzog Harvard University
Thomas Roth
Thomas Roth Wayne State University
Joseph J. Schildkraut
Joseph J. Schildkraut Harvard University
Thomas W. Smith
Thomas W. Smith University of California, Davis
Ross J. Baldessarini
Ross J. Baldessarini Harvard University
Floyd R. Sallee
Floyd R. Sallee University of Cincinnati
Mark Sullivan
Mark Sullivan University of Southampton

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Interested in healthcare, but not sure if becoming a physician is your only path? There are several rewarding alternatives that offer flexibility and growth, especially through online programs.

Earning a bachelors in health administration can open doors to leadership roles in hospitals, clinics, and insurance companies. If you’re considering advancing further, online options for the cheapest mha programs online provide specialized training for those wanting to lead healthcare organizations.

For nursing professionals, pursuing the cheapest dnp program online can help you reach the highest clinical expertise, preparing you for advanced practice or healthcare policy roles. Alternatively, if pharmacy interests you, choose a pharmacy school online accredited by reputable bodies to ensure eligibility for licensure upon graduation.

Each pathway offers unique opportunities and is ideal for those seeking career flexibility, affordable options, or specializations beyond traditional medical school.

Best Scientists Citing Jerold S. Harmatz

Trending Scientists

Recently Published Articles